Weight scale displaying a heart with glowing arteries, representing cardiovascular risk associated with metabolic health.

Beyond BMI: Are You Metabolically Unhealthy at a Normal Weight?

"New research reveals hidden cardiovascular risks in individuals with normal weight but metabolic abnormalities, urging a re-think of current screening guidelines."


For years, excess weight has been linked to metabolic problems. However, studies show that not everyone who is overweight or obese experiences metabolic dysfunction. This led to the concept of metabolically healthy obesity, where individuals with a high BMI don't show the typical signs of metabolic disturbance.

Recent research has challenged the idea that being overweight without metabolic issues is harmless. Studies have consistently shown that metabolically healthy obese individuals fall somewhere between healthy lean individuals and metabolically unhealthy obese individuals in terms of cardiovascular disease (CVD) risk. And surprisingly, those who are metabolically unhealthy but at a normal weight also face increased risks.

A groundbreaking study published in the Journal of the American College of Cardiology digs deeper into this issue. By analyzing data from over 3.5 million people, researchers are shedding light on the hidden dangers of metabolic dysfunction, regardless of weight. This article explores the study's key findings and what they mean for your heart health.

AI Search Multiple angles on this topic

From Risk Clusters to Prevention

Studies of people at high risk have used anthropometric measures, metabolic characteristics, and genetics in cluster analyses to propose novel metabolic subphenotypes. The value of grouping cardiometabolic risk factors into metabolic-health and risk clusters for predicting, preventing, and treating cardiometabolic disease remains an open question. A 2026 perspective argues that future cardiovascular prevention will need dynamic, context-aware risk models linked to implementation strategies, so predictions can inform clinical decisions and population health. (Reference URL 1; Reference URL 2)

Risk Across the Life Course

A 2016 article noted that guidelines focused on risk assessment later in life could miss earlier transitions in metabolic risk that may offer opportunities to avert future disease. Research has also examined trajectories of metabolic risk factors and biochemical markers during the 18 years before cardiovascular disease diagnosis. The developmental-origins framework gained attention in the latter part of the 20th century, alongside growing observational evidence linking early-life factors with later cardiometabolic risk. (Reference URL 1; Reference URL 2)

The Hidden Risk: Metabolic Dysfunction in Normal Weight Individuals

Weight scale displaying a heart with glowing arteries, representing cardiovascular risk associated with metabolic health.

The study by Caleyachetty et al. (2017) confirmed that even without obesity, metabolic abnormalities pose a significant risk. Using electronic health records from millions of individuals, they discovered that normal weight individuals with metabolic dysfunction also faced an increased risk of CVD. This is particularly concerning because it's easy to overlook risk factors in people who appear healthy based on their weight.

The researchers looked at a range of metabolic abnormalities, including diabetes, hyperlipidemia (high cholesterol), and hypertension (high blood pressure). The more abnormalities present, the higher the risk, regardless of a person's weight. This highlights a critical gap in how we currently screen for cardiovascular risk.

  • Normal weight individuals with metabolic dysfunction had hazard ratios ranging from 1.5 to 2.5 for various CVD outcomes.
  • Having three or more metabolic abnormalities made weight irrelevant as a risk factor.
  • The findings suggest a need for increased screening in normal weight populations, particularly in Asian populations where lower BMI cutoffs for overweight may be more appropriate.
AI Search Multiple angles on this topic

Weight and Metabolic Health Can Diverge

In the Japanese JMS cohort study, metabolically unhealthy underweight participants had approximately three times the risk of cardiovascular mortality compared with metabolically healthy normal-weight participants, regardless of age. A JACC Health Promotion Series review says it remains unclear whether observed differences between groups reflect obesity itself or differences in cardiorespiratory fitness. Together, these sources highlight that BMI and metabolic or fitness characteristics do not necessarily tell the same risk story. (Reference URL 1; Reference URL 2)

Current guidelines often focus on weight as a primary indicator for CVD screening. For example, the American Diabetes Association recommends screening for diabetes beginning at age 45 for everyone, and earlier for overweight and obese individuals with risk factors. However, the new research suggests that these guidelines may not be enough.

Time for a New Approach to Heart Health Screening?

The Caleyachetty et al. study, along with other recent research, challenges the traditional focus on weight as the primary determinant of cardiovascular risk. Obesity undoubtedly increases risk, but metabolic dysfunction carries its own weight, regardless of BMI.

AI Search Multiple angles on this topic

Projected Burden and Emerging Treatments

A 2023 review reported that reference forecasts for 2040 placed high blood pressure, high BMI, and high fasting plasma glucose among the top 20 global risk factors for years of life lost. A 2025 review describes using epidemiological data on the cardiovascular–liver–metabolic disease syndemic to examine current and future burden projections. Separately, a report from ADA 2026 describes a growing medication pipeline and ongoing research into treatments addressing obesity, cardiovascular risk reduction, and metabolic disease; it notes that evidence is still emerging. (Reference URL 1; Reference URL 2)

Connected Conditions, Coordinated Care

The American Heart Association introduced the cardiovascular–kidney–metabolic (CKM) syndrome in 2023 as a staged framework for characterizing interconnected cardiovascular, kidney, and metabolic disorders, which jointly increase atherosclerotic burden and mortality risk. The Harrow CRM Hub project describes a personalized, multidisciplinary preventive primary-care model for cardiorenal metabolic disease, a combination of conditions including obesity, diabetes, hypertension, cardiovascular disease, and chronic kidney disease. Its stated aims include slowing CKD progression, reducing cardiovascular risk, and improving quality of life. (Reference URL 1; Reference URL 2)

These findings support the need for more comprehensive screening guidelines that consider metabolic factors beyond just weight. The U.S. guidelines for screening of CVD in persons age older than 18 years, should perhaps be extended to encourage acting upon findings that suggest metabolic risk to reduce cardiovascular morbidity and mortality.

It's important to talk to your doctor about your individual risk factors and whether additional screening is appropriate for you. By taking a proactive approach to heart health, you can reduce your risk of cardiovascular disease and live a longer, healthier life.

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1016/j.jacc.2017.07.742, Alternate LINK

Title: More Appropriate Cardiovascular Risk Screening Through Understanding Complex Phenotypes

Subject: Cardiology and Cardiovascular Medicine

Journal: Journal of the American College of Cardiology

Publisher: Elsevier BV

Authors: Jennifer W. Bea, Nancy K. Sweitzer

Published: 2017-09-01

Everything You Need To Know

1

What is metabolic dysfunction, and why is it important in understanding cardiovascular risk?

Metabolic dysfunction refers to a cluster of conditions such as diabetes, hyperlipidemia, and hypertension, which can negatively impact health. The Caleyachetty et al. (2017) study analyzed data from over 3.5 million people and found that individuals with a normal weight, but exhibiting these metabolic abnormalities, still faced an increased risk of cardiovascular disease. This is significant because it reveals that cardiovascular risk is not solely determined by weight and that metabolic health is a crucial, independent factor. Implications include the need for more comprehensive screening methods that consider metabolic health, not just weight.

2

How does metabolic dysfunction in normal weight individuals affect cardiovascular disease risk?

The research indicates that even if a person's weight is within a normal range, the presence of metabolic dysfunction can elevate the risk of cardiovascular disease. The study by Caleyachetty et al. (2017) showed that normal-weight individuals with metabolic abnormalities had hazard ratios ranging from 1.5 to 2.5 for various CVD outcomes. This suggests that weight alone is not a sufficient indicator of heart health. The implications here are that current screening guidelines, which primarily consider weight, may overlook a significant portion of the population at risk. This underscores the importance of assessing metabolic health independently of weight.

3

What happens to cardiovascular risk when someone has multiple metabolic abnormalities?

The study by Caleyachetty et al. (2017) investigated the impact of multiple metabolic abnormalities. It found that having three or more metabolic abnormalities made a person's weight less relevant as a risk factor for cardiovascular disease. This implies that the severity of metabolic dysfunction, rather than weight, becomes the dominant factor in determining the risk. The implications are that healthcare professionals need to broaden their assessment criteria to include a more detailed examination of metabolic health, such as checking for diabetes, hyperlipidemia, and hypertension, irrespective of a person's BMI.

4

How do current heart health screening guidelines compare with the new research findings?

Current guidelines, like those from the American Diabetes Association, often use weight and BMI as primary factors for screening. However, the research, including the study by Caleyachetty et al. (2017), challenges this approach. It suggests that focusing solely on weight may miss individuals with a normal weight who have metabolic dysfunction, thereby increasing their cardiovascular disease risk. The implications are that there is a need to re-evaluate and update existing screening methods to include a comprehensive assessment of metabolic health, regardless of weight.

5

How does the concept of metabolically healthy obesity relate to the new research?

The concept of metabolically healthy obesity refers to individuals who are obese but do not exhibit typical signs of metabolic disturbance, such as diabetes or high blood pressure. Initially, it was believed that these individuals faced a lower cardiovascular risk compared to those with metabolically unhealthy obesity. However, the research presented by Caleyachetty et al. (2017) shows that normal weight individuals with metabolic dysfunction are still at increased risk. The implications are that a more nuanced approach to assessing cardiovascular risk is needed, moving beyond simply categorizing people by weight and considering their overall metabolic health.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.